Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease

Yonsei Medical Journal

Volumn 37, Issue 5, 1996, Pages 357-363

  Lee, Hong Kyu ^b   Kim, Dong Soo ^a   Noh, Geun Woong ^a   Lee, Ki Young ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Sowha Children s Hospital   (South Korea)

Author keywords

B cell; CD5+ B cell; intravenous immune globulin; Kawasaki disease; T cell

Indexed keywords

ACETYLSALICYLIC ACID; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN;

ARTICLE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPHENOTYPING; IMMUNOREGULATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

EID: 0030443450     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1996.37.5.357     Document Type: Article

References (23)

1. Andersson UG, Bjork L, Skansen-Saphir U, Anderssen JP: Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 79: 211-216, 1993
2. Durandy A, Fisher A, Griscelli C: Dysfunction of pokeweed mitogen-stimulated T and B lymphocyte response induced by gammaglobulin therapy. J Clin Invest 67: 867-877, 1981
3. Furusho K, Nakano H, Shinomiya K, Furusho K, Tamura T, Manabe Y, Kawarano M, Baba K, Kamiya T, Kiyosawa N, Hayashidera T, Hirose O, Yokoyama T, Baba K, Mori C: High-dose intravenous gammaglobulin for Kawasaki disease. Lancet ii: 1055-1058, 1984
4. Guzman J, Fung M, Petty RE: Diagnostic value of antineutrophil cytoplasmic and antiendothelial cell antibodies in early Kawasaki disease. J Pediatr 124: 917-920, 1994
5. Hall PD: Immunomodulation with intravenous immunoglobulin. Pharmacotherapy 13: 564-573, 1993
6. Kawasaki T: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: Clinical observations of 50 cases. Jpn J Allergol 16: 178-222, 1967
7. Kobayashi S, Wada N, Kubo M: Antibodies to native type III collagen in the serum of patients with Kawasaki disease. Eur J Pediatr 151: 183-187, 1992
8. Kondo N, Ozawa T, Mushiake K, Motoyoshi F, Kameyama T, Kasahara K, Kaneko H, Yamashina M, Kato Y, Orii T: Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. J Clin Immunol 11: 152-158, 1991
9. Leung DYM: Immunomodulation by intravenous immune globulin in Kawasaki disease. J Allergy Clin Immunol 84: 588-594, 1989
10. Leung DYM, Burns JC, Newburger JW, Geha RS: Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 79: 468-472, 1987
11. Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS: IgM antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 77: 1428-1435, 1986
12. Luzi G, Ferrara R: Immunoregulation of autoimmune disorders: the role of intravenous immunoglobulins. Int J Artifial Organs 16: 189-195, 1993
13. Noh GW, Kim DS: Decreased CD5+ B cells in Kawasaki disease and increased CD5+ B cells after IVIG treatment. (Abstract) FASEB J 9: A1032, 1995
14. Nonoyama S: Immunoglobulin abnormalities and endothelial cell injury in Kawasaki disease. Ada Paediatr Jpn 33: 752-755, 1991
15. Orvieto R, Achiron A, Ben-Rafael Z, Hagay Z, Achiron R: The possible role of intravenous immunoglobulin in preventing pre-eclamsia. Med Hypotheses 41: 160-164, 1993
16. Phelps SJ, Reynolds MS, Tami JA, Wordell CJ, Howrie D, Dolgin J (ASHP Commission on therapeutics): ASHP therapeutic guidelines for intravenous immune globulin. Clin Pharmacy 11: 117-136, 1992
17. Saulsbury FT: The effect of intravenous immune globulin on lymphocyte populations in children with Kawasaki disease. Clin Exp Rheumatol 10: 617-620, 1992
18. Schroeder HW Jr, Dighiero G: The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire. Immunol Today 15: 288-294, 1994
19. Skanssen-Saphir U, Anderssen J, Bjork L, Anderssen U: Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG. Eur J Immunol 24: 916-922, 1994
20. Stohl W: Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol 62: 200-207, 1985
21. Toyoda M, Zhand X, Petrosian A, Galera OA, Wang SJ, Jordan SC: Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin. J Clin Immunol 14: 178-189, 1994
22. Vassilve T, Gelin C, Kaveri SV, Zilber MT, Boumsell L, Kazatchkine MD: Antibodies to the CDS molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulin, IVIG). Clin Exp Immunol 92: 369-372, 1993
23. Yokoda S: Heat shock protein as a predisposing and immunopotentiating factor in Kawasaki disease. Acta Paediatr Jpn 33: 756-764, 1991